Home
Biofil Chemicals & Pharmaceuticals Ltd PE Ratio

Biofil Chemicals & Pharmaceuticals Ltd
NSE: BIOFILCHEM
PE
Key Highlights
- The P/E Ratio of Biofil Chemicals & Pharmaceuticals Ltd is 116.6 as of 27 Mar 12:51 PM .
- The P/E Ratio of Biofil Chemicals & Pharmaceuticals Ltd changed from 10 on March 2020 to 137.2 on March 2024 . This represents a CAGR of 68.84% over 5 years.
- The Latest Trading Price of Biofil Chemicals & Pharmaceuticals Ltd is ₹ 43.39 as of 27 Mar 12:40 .
- The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
- The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.2. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.1 in 2024.
Historical P/E Ratio of Biofil Chemicals & Pharmaceuticals Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Biofil Chemicals & Pharmaceuticals Ltd
Company Fundamentals for Biofil Chemicals & Pharmaceuticals Ltd

Biofil Chemicals & Pharmaceuticals Ltd
NSE: BIOFILCHEM
Share Price
Market Price of Biofil Chemicals & Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
26 Mar 2025 | 43.14 |
25 Mar 2025 | 45.13 |
24 Mar 2025 | 48.49 |
21 Mar 2025 | 44.64 |
20 Mar 2025 | 44.03 |
19 Mar 2025 | 43.31 |
18 Mar 2025 | 43.97 |
17 Mar 2025 | 43.63 |
13 Mar 2025 | 43.84 |
12 Mar 2025 | 44.9 |
SWOT Analysis Of Biofil Chemicals & Pharmaceuticals Ltd
BlinkX Score for Biofil Chemicals & Pharmaceuticals Ltd
Asset Value vs Market Value of Biofil Chemicals & Pharmaceuticals Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/E Ratio
Company | Market Cap | PE Ratio |
---|
Biofil Chemicals & Pharmaceuticals Ltd | 70.19 | 116.59 |
Sun Pharmaceutical Industries Ltd | 421731 | 35.8 |
Divis Laboratories Ltd | 155019 | 75.0 |
Cipla Ltd | 119164 | 23.9 |
Torrent Pharmaceuticals Ltd | 108956 | 58.5 |
Mankind Pharma Ltd | 99332 | 48.7 |
Company | |
---|---|
Biofil Chemicals & Pharmaceuticals Ltd | 70.19 |
Sun Pharmaceutical Industries Ltd | 421731 |
Divis Laboratories Ltd | 155019 |
Cipla Ltd | 119164 |
Torrent Pharmaceuticals Ltd | 108956 |
Mankind Pharma Ltd | 99332 |
PE Ratio of Biofil Chemicals & Pharmaceuticals Ltd Explained
₹70.19
Market cap
₹0
Earnings
116.6X
PE Ratio
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.
P/E Ratio Formula
P/E ratio = (CMP of share/ Earning per share)
Types of Price to Earning Ratio
1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
PE Ratio of Pharmaceuticals Industry over time
PE Ratio of Top Sectors
Historical Market Cap of Biofil Chemicals & Pharmaceuticals Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Biofil Chemicals & Pharmaceuticals Ltd
Historical Revenue, EBITDA and Net Profit of Biofil Chemicals & Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Biofil Chemicals & Pharmaceuticals Ltd
Revenue
EBITDA
Net Profit
Historical Dividend Payout of Biofil Chemicals & Pharmaceuticals Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payout of Biofil Chemicals & Pharmaceuticals Ltd
About Biofil Chemicals & Pharmaceuticals Ltd
- Biofil Chemicals & Pharmaceuticals Limited (BCPL) was incorporated as a Private Limited Company on 4 Jan.'85 for manufacturing and trading of Pharmaceuticals products.
- Later on, the Company was converted into a Public Limited Company on 7 May '92.
- The Company deals in providing job work facility in respect of manufacturing of pharmaceuticals drug.
- It runs the business via two unit viz Pharmaceutical Division & Chemicals Division. In Feb.'96, the company had come out with a rights-cum-public issue at a premium of Rs 7.50 and at a premium of Rs 12.50 respectively, both aggregating Rs 23.21 cr, to part-finance its expansion and diversification into bulk drugs and pharmaceutical formulations.
- The company currently manufactures pharmaceutical formulations like injections, capsules, eye-drops and dry syrups at its plant located in Indore.
Biofil Chemicals & Pharmaceuticals Ltd News Hub
Biofil Chemicals & Pharmaceuticals standalone net profit declines 29.17% in the June 2024 quarter
Net profit of Biofil Chemicals & Pharmaceuticals declined 29.17% to Rs 0.17 crore in the quarter end
Read more
14 Aug 24
Biofil Chemicals & Pharmaceuticals to table results
Biofil Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 1
Read more
12 Aug 24
Biofil Chemicals & Pharmaceuticals AGM scheduled
Biofil Chemicals & Pharmaceuticals announced that the 39th Annual General Meeting (AGM) of the compa
Read more
10 Sept 24
Biofil Chemicals & Pharmaceuticals to conduct board meeting
Biofil Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 1
Read more
08 Nov 24